Anura David

Anura David is a clinical microbiology researcher whose work centers on improving diagnostic strategies for tuberculosis and related co-infections in high-burden settings, particularly in Southern Africa. Affiliated with collaborative laboratory networks and clinical research sites, the research integrates molecular diagnostics, implementation science, and laboratory systems strengthening to enhance equitable access to rapid testing.

The publication record reflects strong expertise in evaluating nucleic acid amplification tests for detection of Mycobacterium tuberculosis and drug resistance, including rifampicin and isoniazid resistance. Studies assess diagnostic accuracy, feasibility, workflow integration, and reflex testing approaches, with emphasis on real-world laboratory performance and turnaround time improvements.

Recent work highlights innovative specimen strategies such as self-collected tongue swabs, multi-specimen testing in people living with HIV, and integrated TB–COVID-19 co-testing from single samples. Contributions extend to cost and placement analyses of moderate-complexity platforms, supporting policy-relevant decisions for scalable, patient-centered TB diagnostics in resource-limited environments.